Latest filings (excl ownership)
424B3
Prospectus supplement
13 Dec 10
EFFECT
Notice of effectiveness
10 Dec 10
UPLOAD
Letter from SEC
30 Nov 10
D
$400M in debt / Subsidiary Guarantees, sold $400M, 5 investors
6 Oct 10
8-K
Inverness Medical Innovations, Inc. Extends Exchange Offer for 7.875% Senior Notes due 2016
25 May 10
424B3
Prospectus supplement
23 Apr 10
EFFECT
Notice of effectiveness
21 Apr 10
POSASR
Automatic shelf registration (post-effective amendment)
29 Mar 10
D
$100M in debt / Subsidiary Guarantees, sold $100M, 3 investors
13 Oct 09
424B5
Prospectus supplement for primary offering
6 Aug 09
424B5
Prospectus supplement for primary offering
4 Aug 09
POSASR
Automatic shelf registration (post-effective amendment)
4 Aug 09
8-A12B
Registration of securities on exchange
12 May 09
424B5
Prospectus supplement for primary offering
8 May 09
424B5
Prospectus supplement for primary offering
4 May 09
S-3ASR
Automatic shelf registration
10 Apr 09
424B3
Prospectus supplement
16 Feb 05
S-4
Registration of securities issued in business combination transactions
1 Jul 04
15-12G
Securities registration termination
2 Jul 03
8-K
Other events
23 Jun 03
425
Business combination disclosure
29 May 03
10-Q
2003 Q1
Quarterly report
14 May 03
8-K
Financial statements and exhibits
22 Apr 03
10-K
2002 FY
Annual report
24 Mar 03
8-K
Other events
4 Mar 03
8-A12G/A
Registration of securities (amended)
21 Feb 03
425
Business combination disclosure
20 Feb 03
8-K
Other events
20 Feb 03
425
Business combination disclosure
19 Feb 03
425
Business combination disclosure
19 Feb 03
425
Business combination disclosure
2 Jan 03
425
Business combination disclosure
2 Jan 03
8-K
Inverness Medical Innovations and Ostex International Provide Merger Update
2 Jan 03
10-Q
2002 Q3
Quarterly report
14 Nov 02
Latest ownership filings
No filings